Sort
21,281 grants matching “influenza”
Influence of maternal antibodies on a Sendai virus-vectored RSV vaccine
$617,512Julia L Hurwitz · St. Jude Children'S Research Hospital · R01 · FY2012 · AI
Inflammation and Therapy for Respiratory Virus Infection
$617,502Helene Rosenberg · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Mechanistic evaluation of the role of circadian rhythms in acute lung injury and subsequent recovery
$617,048Shaon Sengupta · Children'S Hosp Of Philadelphia · R01 · FY2024 · HL
VTEU: Phase I Influenza Vaccine Clinical Trial
$617,036David Bernstein · Cincinnati Childrens Hosp Med Ctr · N01 · FY2016 · AI
Fluorescence Activated Cell Sorter
$616,949Tony N. Marion · University Of Tennessee Health Sci Ctr · S10 · FY2023 · OD
Roles of tissue-resident helper T cells in mucosal immunity against influenzainfection
$616,876Jie Sun · University Of Virginia · R01 · FY2022 · AI
Designing T-cell Based HIV Vaccines using Peptide-MHC Surface Morphology
$616,751Ha Youn Lee · University Of Southern California · R01 · FY2017 · AI
Efficacy of Dendritic Cell Vaccines Targeting CMV in Glioblastoma (phase 2 DC vaccine)
$616,384Duane A. Mitchell · University Of Florida · R01 · FY2016 · CA
Impact of versican deficiency on the innate immune response to influenza virus
$616,343Charles Wayne Frevert · University Of Washington · R01 · FY2021 · AI
Impact of versican deficiency on the innate immune response to influenza virus
$616,343Charles Wayne Frevert · University Of Washington · R01 · FY2020 · AI
Impact of versican deficiency on the innate immune response to influenza virus
$616,343Charles Wayne Frevert · University Of Washington · R01 · FY2022 · AI
Host dependence of influenza A virus reassortment
$616,281Anice C Lowen · Emory University · R01 · FY2019 · AI
Respiratory Viruses and Airflow Obstruction after HCT
$615,972Michael J Boeckh · Fred Hutchinson Cancer Research Center · R01 · FY2007 · HL
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)
$615,897Ann R Falsey · University Of Rochester · UM1 · FY2020 · AI
Recurrent otitis media and COPD: immunity and vaccines
$615,821State University Of New York At Buffalo · P01 · FY2004 · AI
IL-2 Family Cytokines and their Receptors--Biology of the IL-7/TSLP Systems
$615,820Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Recurrent otitis media and COPD: immunity and vaccines
$615,684State University Of New York At Buffalo · P01 · FY2003 · AI
Genetics of Coxiella burnetii
$615,587Robert A Heinzen · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Eosinophils as Effectors of Antibacterial Immunity in the Lungs
$615,455Amali Samarasinghe · University Of Tennessee Health Sci Ctr · R01 · FY2024 · HL
Impact of versican deficiency on the innate immune response to influenza virus
$615,325Charles Wayne Frevert · University Of Washington · R01 · FY2019 · AI
New mouse model to better predict human immunity to influenza vaccination and infection
$615,280David Masopust · University Of Minnesota · R01 · FY2023 · AI
New mouse model to better predict human immunity to influenza vaccination and infection
$615,280David Masopust · University Of Minnesota · R01 · FY2021 · AI
New mouse model to better predict human immunity to influenza vaccination and infection
$615,280David Masopust · University Of Minnesota · R01 · FY2024 · AI
New mouse model to better predict human immunity to influenza vaccination and infection
$615,280David Masopust · University Of Minnesota · R01 · FY2022 · AI
Complement Receptors in Humoral Immunity to Influenza
$615,212Michael Craig Carroll · Harvard Medical School · P01 · FY2008 · AI